Inactive Instrument

News AlerisLife Inc.

Equities

FVE

US33832D2053

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

ALERISLIFE INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-03-20	AQ
AlerisLife Announces Closing of Tender Offer	23-03-20	BU
AlerisLife Inc.(NasdaqCM:ALR) dropped from NASDAQ Composite Index	23-03-20	CI
AlerisLife Inc.(NasdaqCM:ALR) dropped from S&P TMI Index	23-03-20	CI
ABP Acquisition LLC completed the acquisition of the remaining 93.7% stake in AlerisLife Inc. from Diversified Healthcare Trust and others.	23-03-19	CI
North American Morning Briefing : Futures Deep in -3-	23-03-15	DJ
ALERISLIFE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AlerisLife Inc. - ALR	23-02-24	BU
ALERISLIFE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AlerisLife Inc. - ALR	23-02-07	BU
AlerisLife Agrees to Be Acquired by ABP Acquisition for $43.8 million; AlerisLife Shares Surge Pre-Bell	23-02-03	MT
AlerisLife Agrees to be Acquired by ABP Acquisition for $43.8 million; Shares Halted Pre-Bell	23-02-03	MT
ALERISLIFE INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-03	AQ
ABP Acquisition to Acquire AlerisLife for $1.31 Per Share	23-02-03	BU
ABP Acquisition LLC entered into an agreement to acquire the remaining 93.7% stake in AlerisLife Inc. from Diversified Healthcare Trust and others for $41.2 million.	23-02-02	CI
ALERISLIFE INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-11-10	AQ
B. Riley Securities Trims AlerisLife's Price Target to $1.50 From $2 After Mixed Q3 Results, Keeps Neutral Rating	22-11-07	MT
Transcript : AlerisLife Inc., Q3 2022 Earnings Call, Nov 03, 2022	22-11-03
Five Star: Q3 Earnings Snapshot	22-11-02	AQ
Earnings Flash (ALR) ALERISLIFE Posts Q3 Revenue $182.7M, vs. Street Est of $179M	22-11-02	MT
ALERISLIFE INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-02	AQ
AlerisLife Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AlerisLife Inc.

Equities

FVE

US33832D2053

Summary

Filters